[go: up one dir, main page]

WO2002040698A3 - Analyse de marqueurs biologiques de facteurs solubles - Google Patents

Analyse de marqueurs biologiques de facteurs solubles Download PDF

Info

Publication number
WO2002040698A3
WO2002040698A3 PCT/US2001/043583 US0143583W WO0240698A3 WO 2002040698 A3 WO2002040698 A3 WO 2002040698A3 US 0143583 W US0143583 W US 0143583W WO 0240698 A3 WO0240698 A3 WO 0240698A3
Authority
WO
WIPO (PCT)
Prior art keywords
analysis
biological markers
soluble factor
factor biological
microparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/043583
Other languages
English (en)
Other versions
WO2002040698A2 (fr
Inventor
Rajendra Singh
Remy Cromer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alavita Pharmaceuticals Inc
Original Assignee
Surromed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Surromed Inc filed Critical Surromed Inc
Priority to AU2002237662A priority Critical patent/AU2002237662A1/en
Publication of WO2002040698A2 publication Critical patent/WO2002040698A2/fr
Publication of WO2002040698A3 publication Critical patent/WO2002040698A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

L'invention concerne des dosages biologiques multiplex de facteurs reposant sur la cytométrie de flux, ainsi que les procédés et les réactifs associés. Ces procédés consistent à utiliser des microparticules de déclenchement et des microparticules de détection pour former des complexes contenant des facteurs solubles. L'invention concerne par ailleurs des procédés de détection et de quantification de ces complexes dans des dosages biologiques multiplex par cytométrie de flux.
PCT/US2001/043583 2000-11-17 2001-11-15 Analyse de marqueurs biologiques de facteurs solubles Ceased WO2002040698A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002237662A AU2002237662A1 (en) 2000-11-17 2001-11-15 Analysis of soluble factor biological markers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71586500A 2000-11-17 2000-11-17
US09/715,865 2000-11-17

Publications (2)

Publication Number Publication Date
WO2002040698A2 WO2002040698A2 (fr) 2002-05-23
WO2002040698A3 true WO2002040698A3 (fr) 2002-08-22

Family

ID=24875788

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/043583 Ceased WO2002040698A2 (fr) 2000-11-17 2001-11-15 Analyse de marqueurs biologiques de facteurs solubles

Country Status (2)

Country Link
AU (1) AU2002237662A1 (fr)
WO (1) WO2002040698A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018495A1 (en) * 2002-07-24 2004-01-29 Xing-Xiang Li Microparticle based signal amplification for the detection of analytes
AU2003903417A0 (en) 2003-07-04 2003-07-17 Genera Biosystems Pty Ltd Multiplex detection
US7361410B2 (en) * 2003-12-29 2008-04-22 Intel Corporation External modification of composite organic inorganic nanoclusters comprising raman active organic compound
US20050191665A1 (en) * 2003-12-29 2005-09-01 Xing Su Composite organic-inorganic nanoclusters
WO2005071401A2 (fr) * 2004-01-15 2005-08-04 Chiron Corporation Dosage multiplex homogene pour des cibles d'acides nucleiques
US7776547B2 (en) 2004-08-26 2010-08-17 Intel Corporation Cellular analysis using Raman surface scanning
US7285427B2 (en) * 2004-10-06 2007-10-23 General Electric Company Raman-active particles and methods of making and using them
ATE467127T1 (de) 2004-10-12 2010-05-15 Luminex Corp Verfahren zur veränderung der oberflächeneigenschaften von mikrokügelchen
BRPI0518405B8 (pt) 2004-12-10 2021-07-27 Genera Biosystems Pty Ltd conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica
WO2007054714A2 (fr) * 2005-11-12 2007-05-18 Platform Diagnostics Limited Analyse par agglutination

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891656A (en) * 1992-09-14 1999-04-06 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US6337184B1 (en) * 1997-04-01 2002-01-08 Jeffrey B. Miller Molecular marker for muscle stem cells
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US5891656A (en) * 1992-09-14 1999-04-06 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US6337184B1 (en) * 1997-04-01 2002-01-08 Jeffrey B. Miller Molecular marker for muscle stem cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FULTON ET AL.: "Advanced multiplexed analysis with the flowmetrix TM system", CLINICAL CHEMISTRY, vol. 43, no. 9, 19 June 1997 (1997-06-19), pages 1749 - 1750 *

Also Published As

Publication number Publication date
AU2002237662A1 (en) 2002-05-27
WO2002040698A2 (fr) 2002-05-23

Similar Documents

Publication Publication Date Title
CA2320418A1 (fr) Methodes et reactifs pour l'isolation rapide et efficace de cellules cancereuses circulantes
PT2280283E (pt) Células marcadas para uso como controlo funcional interno em ensaios de deteção de células raras
WO2002004918A3 (fr) Capteur immunologique a membrane nanoporeuse
AU1038402A (en) Assay for directly detecting a rs virus related biological cell in a body fluid sample
WO2001018252A3 (fr) Methodes de detection de maladies
WO2003062787A3 (fr) Dosage biologique et identification biomoleculaire, procedes de tri et de collecte utilisant des microspheres magnetiques
EP1624307A3 (fr) Méthode pour détecter l'hémoglobine glycosylée ou glyquée (HbA1c)
WO2004046164A3 (fr) Sequences de reconnaissance uniques et leurs procedes d'utilisation dans l'analyse de proteines
WO2003002976A3 (fr) Procedes et reactifs de detection d'endotoxines
WO2002040698A3 (fr) Analyse de marqueurs biologiques de facteurs solubles
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2002094778A3 (fr) Conjugues peptidiques et procedes de detection de fluorescence pour dosage de la caspase intracellulaire
WO2002059599A3 (fr) Systeme et methode pour analyse in vitro d'agents therapeutiques
EP2088206A3 (fr) Induction de la transition de perméabilité mitochondriale
CA2467904A1 (fr) Compositions et methodes pour le diagnostic precoce precis de la grossesse
CA2407760A1 (fr) Methodes pour le diagnostic de l'astrocytome de bas grade
EP1392362A4 (fr) Detection de legionella par transfert d'energie a resonance fluorescente
WO2002048398A3 (fr) Systeme d'hybridation in situ de mise en evidence specifique de micro-organismes
WO2006029302A3 (fr) Assemblages de nanoparticules de dioxetane pour des systemes de detection de transfert d'energie, methodes de fabrication de ces assemblages, et methodes d'utilisation de ces assemblages dans des bioanalyses
WO2002086505A3 (fr) Analyse intracellulaire
WO2006099537A3 (fr) Utilisation de systemes d'antigenes a substituts d'anticorps a des fins de detection d'analytes
WO2002077285A3 (fr) Procedes de detection de la presence de polynucleotides par amplification
CA2350355A1 (fr) Contenant a liquide biologique pour analyse
DK1192443T3 (da) Fremgangsmåde til kvantificering af endotel-mikrosfærer
AU4624200A (en) Identification of ligands for orphan receptors using mass spectrometry

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP